Tetraphase announces second amendment to merger agreement with acelrx pharmaceuticals for increased consideration

Tetraphase pharmaceuticals, inc. (nasdaq:ttph), a biopharmaceutical company focused on commercializing its novel tetracycline xeravatm (eravacycline f

CVI Ratings Summary

CVI Quant Ranking